Barnett, J. H., Jones, P.B., Robbins, T. W., & Muller, U. (2007), ‘Effects of the cathecol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wiscosin Card Sort Test in schizophrenia and healthy control’, vol. 12, no.5, pp. 502-509.
Braver, T., Gray, J., & Buguess, G.C. (2007), ’Explaining the many varieties of working memory variation: Dual Mechanisms of cognitive control’, in ‘Variations in working memory’, pp. 76-106.
Deichmann, R., Shwarzbauer, C., & Turner, R. (2004), ‘Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T’, Neuroimage, vol. 21, pp. 757-767.
Lotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melen, K., Julkunen, I., Taskinen, J., (1995), ‘Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme’, Biochemistry, vol. 34, pp. 4202 - 4210.
Männistö, P.T., & Kaakkola, S. (1999), ‘Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors’, Pharmacological Reviews, vol. 51, no. 4, pp. 593-628.
Nee, D. E., Wager, T. D., & Jonides, J. (2007), ‘Interference resolution: insights from a meta-analysis of neuroimaging tasks’, vol. 7, no. 1, pp. 1-17.
Weinshilboum, R. M., Otterness, D. M., & Szumlanski, C. L. (1999), ‘Methylation pharmacogenetics: cathecol O-methyltransferase, thiopurine methyltransferase, and histamine N-methytransferase’, Annual Review of Pharmacology and Toxicology, vol. 39, pp. 19-52.